Diagnostic Testing Services for Medical Institution Alliances

Yunkang provides solutions to member hospitals in medical institution alliances for building up and managing their diagnostic centers. The on-site diagnostic center is normally located at the lead hospital. Member hospitals within the same medical institution alliance may also use the diagnostic capacities of the center, as they will also deliver their test samples to the diagnostic center for testing. Therefore, our diagnostic testing services for medical institution alliances assist hospitals to better manage their diagnostic operation by centralizing and utilizing their resources to enhance the diagnostic capacities of the whole medical institution alliance.

We Provide Comprehensive Solutions for Medical Institution Alliances

Setting-up or upgrading diagnostic centers

We usually help build up an on-site diagnostic center at the lead hospital in one of the four major therapeutic areas, namely pathology, infectious disease, genetic disease and routine diagnostic tests. We will also provide one to seven technicians to work at the center. In the meantime, the lead hospital will have one to seven personnel working at the center. If lead hospitals do not have sufficient capabilities and/or capacities to perform certain diagnostic tests, we will provide our expertise in diagnostic technologies, on-site staff, IT systems and testing equipment as appropriate to assist them to perform or upgrade the diagnostic testing at such centers.

Establishment of standard operating procedures

Leveraging our knowledge of national and international diagnosis standards, we help medical institutions within the alliances to establish standard operating procedures to enhance their diagnostic testing efficiency and quality management in diagnostic testing.

Diagnostic consultation and staff training

We also offer on-site training and seminars to the staff of medical institutions within the alliances. These trainings primarily cover the standard procedures to handle test samples. We have also established an online consultation platform, under which our customers may upload patients' pathological reports onto the platform. We have engaged external pathologists to review these reports online to provide pathology guidance for hospitals and doctors.

Procurement of equipment

We help medical institutions procure upgraded or new testing equipment to meet the increasing diagnostic demands and enhance their testing capabilities. Major testing equipment used at these on-site diagnostic centers are procured and provided by us. Generally, the testing equipment we provided to them shall be returned to us if the relevant service and collaboration agreement is expired or terminated.

Smart Internet of things

We have established a smart Internet of things platform connecting our testing equipment, which can monitor the status of the testing equipment at these on-site diagnostic centers at our headquarters level. This platform will send the operation and maintenance data of testing equipment at these diagnostic centers to our system so that we can monitor the operating status of testing equipment to ensure the accuracy and efficiency of diagnostic testing, which we believe can enhance customer loyalty. In addition, we also formulated a hierarchical diagnosis and treatment module, which focuses on sharing information and allocating resources among medical institutions within the alliances through intelligent technologies. We will distribute diagnostic information to relevant hospitals online, and help hospitals direct patients to the most appropriate hospital for treatment. Our hierarchical diagnosis and treatment module involves a Yunkang telepathology platform, through which hospitals are able to conduct remote consultation, referral consultation and online transmission of testing results.

Logistics assistance

We also offer logistics services to deliver test samples to the on-site diagnostic centers from member hospitals. As these diagnostic centers are typically built at the lead hospitals, member hospitals may utilize our logistics services to deliver test samples to the corresponding diagnostic centers. In addition, if these diagnostic centers are not capable of performing certain diagnostic tests, the test samples may be delivered directly to our nearby ICLs for diagnostic testing.

Diagnostic testing

Our technicians are involved in the daily operations of the on-site diagnostic centers to perform diagnostic tests at the centers. In addition, medical institutions may also use the diagnostic capacity of our nearby ICLs if these diagnostic centers are not capable of performing certain diagnostic tests. Afterwards, we will issue diagnostic testing reports.

Diagnostic Outsourcing Services

Yunkang offers diagnostic outsourcing services to hospitals, other medical institutions and corporations at various levels. Facing the high volume of patient samples, under the premise of time- and cost-consuming testings performed by the hospitals, Yunkang provides a wide range of medical testing and clinical diagnostic services, including nucleic acid testing, genetic testing and diagnostic testing involving NGS technologies.

Yunkang is operating six independent clinical laboratories in a national scale, encompassing all major clinical laboratory technology platforms, including immunological detection, mass spectrometry, PCR, high-throughput sequencing, liquid chip, ultra-micro pathological morphology and digital pathology remote diagnosis. We have become a platform of medical operation service in China, covering major medical specialties of pathology, infectious diseases and genetic diseases with a growing menu of over 2,000 tests, which covered approximately 70% of major diagnostic testing categories in the medical operation service market in 2020, also over 50 million diagnostic tests performed in 2021.

Pathology tests
Infectious disease diagnostic tests
Genetic disease diagnostic tests
Routine diagnostic tests

Pathology tests

Pathology tests primarily aim to discover and diagnose the nature of tumor. According to Frost & Sullivan, the number of new confirmed cancer cases in China increased from approximately 4.1 million in 2016 to approximately 4.6 million in 2020. Driven by factors including aging population and environmental factors, it is expected that there will be approximately 5.2 million confirmed cancer cases in 2025. Pathology tests are crucial for clinicians to accurately diagnose the pathological condition of each patient, so that they can provide timely, professional and efficient treatment plans.

Infectious disease diagnostic tests

With the growing awareness of infectious diseases, Yunkang has gradually built up our service offerings for over 20 categories of infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus and nucleic acid tests for respiratory pathogens (including COVID-19 virus), among others. In particular, since the occurrence of COVID-19 pandemic, COVID-19 testing has rapidly become a norm in daily life, as it is required for those in close contact with confirmed COVID-19 cases, those engaging international and cross-regional travel, and those having been exposed in high-risk environments. It is reported that Yunkang started to offer relevant professional services for COVID-19 testing (nucleic acid testing) as early as January 2020. Besides, the Guangzhou laboratory of Yunkang was included by the Guangdong Provincial Health Commission (廣東省衛生健康委) in the first batch of medical institutions with the COVID-19 nucleic acid testing capability.

Genetic disease diagnostic tests

Genetic disease diagnostic tests cover a very wide range of genetic reproduction tests and screening tests. According to Frost & Sullivan, the PRC government aims to increase the testing capacity of genetic reproduction tests to cover more than 50% of new birth populations in the PRC by 2022. In the field of genetic disease diagnostic testing, Yunkang can offer genetic screening tests at pre-pregnancy, pregnancy and new-born stages, aiming to help hospitals establish genetic pathology data for each patient so that they can design the most suitable treatment plan for the patient. It can even allow mothers to detect and prevent infectious disease and hereditary birth defects at pre-pregnancy and pregnancy stages, beneficial to prenatal and postnatal care.

Routine diagnostic tests

In addition, Yunkang provides certain routine diagnostic tests for chronic kidney disease, blood disease, autoimmune disease, endocrine metabolism disease and other diseases.

Yunkang Group Limited

Yunkang Group Limited